![Figure 1 from Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients | Semantic Scholar Figure 1 from Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e045f1015529a64592642043bc60b3b6f640925a/4-Figure1-1.png)
Figure 1 from Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients | Semantic Scholar
![Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD. - ppt download Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD. - ppt download](https://slideplayer.com/4463260/14/images/slide_1.jpg)
Multitarget Stool DNA Testing for Colorectal-Cancer Screening NEJM April 3, 2014 Vol 3 Imperiale, T.F. et al Presented by Melissa Spera, MD. - ppt download
![Faecal testing for the detection of colorectal cancer - HC Marbella | HC Marbella International Hospital Faecal testing for the detection of colorectal cancer - HC Marbella | HC Marbella International Hospital](https://www.hcmarbella.com/wp-content/uploads/2020/05/test_sangre_oculta_web_eng.jpg)
Faecal testing for the detection of colorectal cancer - HC Marbella | HC Marbella International Hospital
FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test
![Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening | Radiology Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2020201018/asset/images/medium/radiol.2020201018.va.gif)
Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening | Radiology
![mt-sDNA test shows high specificity for colorectal cancer screening in average-risk 45- to 49-year-olds - Mayo Clinic mt-sDNA test shows high specificity for colorectal cancer screening in average-risk 45- to 49-year-olds - Mayo Clinic](https://www.mayoclinic.org/-/media/kcms/gbs/medical-professionals/images/2021/03/02/17/07/colon_cancer_polyps_767.jpg)
mt-sDNA test shows high specificity for colorectal cancer screening in average-risk 45- to 49-year-olds - Mayo Clinic
![Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial | BMC Gastroenterology | Full Text Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial | BMC Gastroenterology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12876-021-01759-9/MediaObjects/12876_2021_1759_Fig1_HTML.png)
Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial | BMC Gastroenterology | Full Text
![Frontiers | Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer Frontiers | Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer](https://www.frontiersin.org/files/Articles/536785/fgene-11-00324-HTML/image_m/fgene-11-00324-g001.jpg)
Frontiers | Performance Comparison Between Plasma and Stool Methylated SEPT9 Tests for Detecting Colorectal Cancer
![Liquid biopsies to monitor and direct cancer treatment in colorectal cancer | British Journal of Cancer Liquid biopsies to monitor and direct cancer treatment in colorectal cancer | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-022-01769-8/MediaObjects/41416_2022_1769_Fig1_HTML.png)